Showing results (11-20 of 180) with videos related to
Sort By:
Pageof 18
Neurology(R) Neuroimmunology & Neuroinflammation|January 31, 2015
Does MOG Ig-positive AQP4-seronegative opticospinal inflammatory disease justify a diagnosis of NMO spectrum disorder?Scott S Zamvil, Anthony J SlavinNature Reviews. Immunology|April 28, 2006
Statin therapy and autoimmune disease: from protein prenylation to immunomodulationJohn Greenwood, Lawrence Steinman, Scott S ZamvilNeurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|October 9, 2007
Mechanism of action of glatiramer acetate in treatment of multiple sclerosisMartin S Weber, Reinhard Hohlfeld, Scott S ZamvilNeurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|October 9, 2007
Statins--treatment option for central nervous system autoimmune disease?Martin S Weber, Lawrence Steinman, Scott S ZamvilCold Spring Harbor Perspectives in Medicine|January 24, 2018
B-Cell Therapies in Multiple SclerosisJoseph J Sabatino, Scott S Zamvil, Stephen L HauserNature Reviews. Neuroscience|November 28, 2019
Publisher Correction: B cells in autoimmune and neurodegenerative central nervous system diseasesJoseph J Sabatino, Anne-Katrin Pröbstel, Scott S ZamvilCurrent Opinion in Neurology|July 15, 2003
Statins as potential therapeutic agents in neuroinflammatory disordersOlaf Stüve, Sawsan Youssef, Lawrence Steinman, et al.Nature Reviews. Neuroscience|November 13, 2019
B cells in autoimmune and neurodegenerative central nervous system diseasesJoseph J Sabatino, Anne-Katrin Pröbstel, Scott S ZamvilThe Neurologist|December 20, 2007
The immunogenicity of disease-modifying therapies for multiple sclerosis: clinical implications for neurologistsEdward J Fox, Timothy K Vartanian, Scott S ZamvilCurrent Opinion in Immunology|August 26, 2025
B-cell antigen presentation in central nervous system autoimmunityCarson E Moseley, Joseph J Sabatino, Scott S ZamvilPageof 18